PBS Website Update - 1 April 2019
Page last updated: 1 April 2019
The Schedule of Pharmaceutical Benefits was updated on 1 April 2019 and the Summary of Changes can be found on the New, Amended and Deleted Items page.
The following updates have also been made to the PBS Website:
- Formulary Allocations - 1 April 2019
- First New Brand Price Reductions
- Items Exempt from Statutory Price Reductions - 1 April 2019
- Ex-manufacturer price
- Drugs subject to Price Disclosure - 1 April 2019
- General Statement for Drugs for the Treatment of Hepatitis C
- PBS and RPBS Section 85 Date of Supply Data
- A-Z of Biological Drugs and Brands currently listed on the Pharmaceutical Benefits Scheme (PBS)
- Drug Utilisation Sub-Committee (DUSC) Outcome Statement - 29 March 2019
- Recommendations made by the PBAC - August 2018 - 27 March 2019
- Pharmaceutical Benefits Scheme (PBS) Process Improvements Webinar Information Forum - 27 March 2019
- PBAC Report now available - Options for listing PD-(L)1 checkpoint inhibitors for multiple cancer indications on the PBS - 22 March 2019
- PBAC Public Summary Documents - November 2018 meeting (rejections and deferrals) - 15 March 2019
- Drug utilisation Sub-Committee (DUSC) Utilisation Analysis Public Release Documents - 15 March 2019
- Direct-acting Antivirals for Hepatitis C Outcome Statement - 8 March 2019
- Public Consultation – Draft Procedure Guidance and Forms for Listing Medicines on the PBS - 6 March 2019
- PBAC Public Summary Documents - November 2018 meeting - 1 March 2019
